FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2092120209> ?p ?o ?g. }

• W2092120209 endingPage "134" @default.
• W2092120209 startingPage "126" @default.
• W2092120209 abstract "Abstract Background: Nonsteroidal anti-inflammatory drug (NSAID) use has been associated with a reduced risk of colon cancer; further epidemiologic data appear consistent for stomach and esophageal adenocarcinomas. Yet, data on potential confounding effects by upper gastrointestinal tract (UGI) disorders on adenocarcinomas of the UGI are limited. Methods: This study recruited newly diagnosed patients with esophageal adenocarcinoma (n = 220), gastric cardia adenocarcinoma (n = 277), or distal gastric adenocarcinoma (n = 441) as well as 1,356 control subjects in Los Angeles County. Unconditional multivariable logistic regression analyses were done to evaluate the association between regular NSAID use, at least two pills per week for 1 month, and these cancers. Results: Duration of regular use of aspirin and non-aspirin NSAIDs was associated with reduced relative odds of distal gastric adenocarcinoma [&gt;5 years use versus no regular use: odds ratio (OR), 0.61; 95% confidence interval, 0.40-0.92; Ptrend = 0.009] and esophageal adenocarcinoma (OR, 0.60; 95% confidence interval, 0.38-0.95; Ptrend = 0.04) in multivariable models that included history of UGI disorders and other potential confounding factors. Daily regular use was also associated with statistically significant reduced ORs of these two tumor types. No significant heterogeneity in risk estimates was noted after stratification by history of UGI disorders for any of the sites studied. However, irregular users of NSAIDs also had reduced risk of these cancers when compared with nonusers. Conclusions: Results from this study support an inverse association between regular NSAID use and risk of esophageal and distal gastric adenocarcinomas in individuals with and without a history of UGI disorders with long duration and daily use, providing the greatest risk reduction. Reduced risk in irregular users suggests that factors other than an effect on cyclooxygenase may also be important. (Cancer Epidemiol Biomarkers Prev 2008;17(1):126–34)" @default.
• W2092120209 created "2016-06-24" @default.
• W2092120209 creator A5010562868 @default.
• W2092120209 creator A5067191439 @default.
• W2092120209 creator A5072047782 @default.
• W2092120209 creator A5079827557 @default.
• W2092120209 date "2008-01-01" @default.
• W2092120209 modified "2023-09-29" @default.
• W2092120209 title "Nonsteroidal Anti-inflammatory Drugs and Risk of Esophageal and Gastric Adenocarcinomas in Los Angeles County" @default.
• W2092120209 cites W1526269920 @default.
• W2092120209 cites W1632319133 @default.
• W2092120209 cites W1968839103 @default.
• W2092120209 cites W1973075998 @default.
• W2092120209 cites W1990393102 @default.
• W2092120209 cites W1990719139 @default.
• W2092120209 cites W1993228606 @default.
• W2092120209 cites W2006324046 @default.
• W2092120209 cites W2015154916 @default.
• W2092120209 cites W2018240439 @default.
• W2092120209 cites W2022640628 @default.
• W2092120209 cites W2023292042 @default.
• W2092120209 cites W2028667429 @default.
• W2092120209 cites W2034078695 @default.
• W2092120209 cites W2041191993 @default.
• W2092120209 cites W2045512092 @default.
• W2092120209 cites W2051279880 @default.
• W2092120209 cites W2065782696 @default.
• W2092120209 cites W2068806248 @default.
• W2092120209 cites W2070806584 @default.
• W2092120209 cites W2075255580 @default.
• W2092120209 cites W2076092023 @default.
• W2092120209 cites W2079766507 @default.
• W2092120209 cites W2081220178 @default.
• W2092120209 cites W2084078825 @default.
• W2092120209 cites W2086982583 @default.
• W2092120209 cites W2090213224 @default.
• W2092120209 cites W2096451331 @default.
• W2092120209 cites W2108829851 @default.
• W2092120209 cites W2120169362 @default.
• W2092120209 cites W2125968258 @default.
• W2092120209 cites W2135555007 @default.
• W2092120209 cites W2154026266 @default.
• W2092120209 cites W2163762264 @default.
• W2092120209 cites W2192027448 @default.
• W2092120209 cites W2318688094 @default.
• W2092120209 cites W94544284 @default.
• W2092120209 doi "https://doi.org/10.1158/1055-9965.epi-07-0664" @default.
• W2092120209 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18187391" @default.
• W2092120209 hasPublicationYear "2008" @default.
• W2092120209 type Work @default.
• W2092120209 sameAs 2092120209 @default.
• W2092120209 citedByCount "56" @default.
• W2092120209 countsByYear W20921202092012 @default.
• W2092120209 countsByYear W20921202092013 @default.
• W2092120209 countsByYear W20921202092014 @default.
• W2092120209 countsByYear W20921202092016 @default.
• W2092120209 countsByYear W20921202092018 @default.
• W2092120209 countsByYear W20921202092019 @default.
• W2092120209 countsByYear W20921202092021 @default.
• W2092120209 countsByYear W20921202092022 @default.
• W2092120209 countsByYear W20921202092023 @default.
• W2092120209 crossrefType "journal-article" @default.
• W2092120209 hasAuthorship W2092120209A5010562868 @default.
• W2092120209 hasAuthorship W2092120209A5067191439 @default.
• W2092120209 hasAuthorship W2092120209A5072047782 @default.
• W2092120209 hasAuthorship W2092120209A5079827557 @default.
• W2092120209 hasBestOaLocation W20921202091 @default.
• W2092120209 hasConcept C121608353 @default.
• W2092120209 hasConcept C126322002 @default.
• W2092120209 hasConcept C156957248 @default.
• W2092120209 hasConcept C2777628954 @default.
• W2092120209 hasConcept C2779742542 @default.
• W2092120209 hasConcept C2781182431 @default.
• W2092120209 hasConcept C44249647 @default.
• W2092120209 hasConcept C71924100 @default.
• W2092120209 hasConcept C77350462 @default.
• W2092120209 hasConcept C90924648 @default.
• W2092120209 hasConceptScore W2092120209C121608353 @default.
• W2092120209 hasConceptScore W2092120209C126322002 @default.
• W2092120209 hasConceptScore W2092120209C156957248 @default.
• W2092120209 hasConceptScore W2092120209C2777628954 @default.
• W2092120209 hasConceptScore W2092120209C2779742542 @default.
• W2092120209 hasConceptScore W2092120209C2781182431 @default.
• W2092120209 hasConceptScore W2092120209C44249647 @default.
• W2092120209 hasConceptScore W2092120209C71924100 @default.
• W2092120209 hasConceptScore W2092120209C77350462 @default.
• W2092120209 hasConceptScore W2092120209C90924648 @default.
• W2092120209 hasIssue "1" @default.
• W2092120209 hasLocation W20921202091 @default.
• W2092120209 hasLocation W20921202092 @default.
• W2092120209 hasOpenAccess W2092120209 @default.
• W2092120209 hasPrimaryLocation W20921202091 @default.
• W2092120209 hasRelatedWork W1968828885 @default.
• W2092120209 hasRelatedWork W1973459017 @default.
• W2092120209 hasRelatedWork W2043990466 @default.
• W2092120209 hasRelatedWork W2100779789 @default.
• W2092120209 hasRelatedWork W2602431682 @default.
• W2092120209 hasRelatedWork W2793065959 @default.

• next